Built by leaders at the forefront of genetic medicine.
Location: United States
Total raised: $60M
Investors 2
| Date | Name | Website |
| 25.04.2026 | SV Investm... | svinvest.c... |
| 25.04.2026 | Company K ... | kpartners.... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 27.02.2026 | Series B | $60M | - |
Mentions in press and media 2
| Date | Title | Description |
| 27.02.2026 | BreezeBio: $60 Million Series B Raised To Advance Precision Genetic Medicines Pipeline | BreezeBio, formerly known as GenEdit, has closed $60 million in Series B financing to advance its first internal therapeutic programs toward the clinic and expand its NanoGalaxy delivery platform. The South San Francisco-based biotechnology... |
| 26.02.2026 | BreezeBio Closes Series B Funding | BreezeBio, (fka as GenEdit), a San Francisco, CA-based biotechnology company developing genetic medicines, raised an undisclosed amount in Series B funding. The round was led by Yuanta Investment and DSC Investment, with participation from ... |